| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/01/2009 | CN100473586C Lock for a flat and low pourer |
| 03/31/2009 | US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 03/31/2009 | US7511039 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/26/2009 | WO2009038026A1 Ctl inducer composition |
| 03/26/2009 | WO2008157729A3 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 03/26/2009 | WO2005014615A3 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/26/2009 | US20090083880 Modified plant defensin |
| 03/26/2009 | US20090082547 Compositions for enhancing transport of molecules into cells |
| 03/26/2009 | US20090082281 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/26/2009 | US20090082280 peptidomimetics; sextapeptides; for stimulating elastogenesis and capillary dilatation |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082261 Urea-containing peptides as inhibitors of viral replication |
| 03/26/2009 | US20090082259 Deuterium-enriched octreotide |
| 03/26/2009 | US20090082258 Means and Methods for Treating Advanced Stage Neuroblastoma |
| 03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
| 03/26/2009 | US20090081786 Peptide sequences for modulation of protein kinase C |
| 03/26/2009 | US20090081714 Assays |
| 03/26/2009 | US20090081692 Ceramide Kinase Loop |
| 03/26/2009 | US20090081298 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081246 Method for isolating hepatitis c virus peptides |
| 03/26/2009 | US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents |
| 03/26/2009 | US20090081228 Cyr61 compositions and methods |
| 03/26/2009 | US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF |
| 03/26/2009 | US20090081222 Novel splice variants of the egf receptor |
| 03/26/2009 | US20090081186 Methods and compositions for preventing and/or treating pancreatitis |
| 03/26/2009 | US20090081178 Phenolic Binding Peptides |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/26/2009 | CA2700115A1 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 03/26/2009 | CA2697896A1 Ctl inducer composition |
| 03/25/2009 | EP2037942A2 Polymeric biosurfactants |
| 03/25/2009 | EP1888775A4 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 03/25/2009 | CN101395173A Template-fixed peptidomimetics with antimicrobial activity |
| 03/25/2009 | CN101395172A Novel antimicrobial peptides and use thereof |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/25/2009 | CN100471867C Novel method for abstracting vitriol capreomycin |
| 03/24/2009 | US7507805 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507787 Polynucleotides; induce immunology response; antiinflammatory agents; detection polynucleotide patten |
| 03/24/2009 | US7507717 Inhibitors of neuronal amine transporters of neurotransmitters, such as noradrenaline, serotonin, dopamine, glutamic acid and glycine; pain, inflammation, incontinence, cardiovascular conditions and mood disorders |
| 03/24/2009 | US7507711 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2328136C Intramolecularly-quenched near infrared fluorescent probes |
| 03/24/2009 | CA2223911C The preparation of active peptides |
| 03/19/2009 | WO2009035460A1 Methods and compositions for treating melanoma |
| 03/19/2009 | WO2009035169A1 Peptide having anti-hypertensive activity |
| 03/19/2009 | WO2009033233A1 Novel p2x7 epitopes |
| 03/19/2009 | WO2008156637A3 Biocompatible coated nanostructured titanium surfaces |
| 03/19/2009 | WO2008096276A3 Peptide inhibitors of metallo- ectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
| 03/19/2009 | WO2005076886A3 Prostasin substrates and inhibitors |
| 03/19/2009 | US20090076244 Beta Helical Peptide Structures Stable in Aqueous and non-Aqueous Media and Methods for preparing same |
| 03/19/2009 | US20090076176 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 03/19/2009 | US20090075905 Anticancer compounds and methods |
| 03/19/2009 | US20090075904 Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use |
| 03/19/2009 | US20090075902 Inhibiting the signs of aging by inhibiting nf-kappa b activation |
| 03/19/2009 | US20090075900 Therapeutic agent for motor neuron disease |
| 03/19/2009 | US20090075899 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 03/19/2009 | US20090075898 Complement C3A Derived Peptides and Uses Thereof |
| 03/19/2009 | US20090075897 Peptides derived from the C2 domain of epsilon PKC and methods of use, thereof |
| 03/19/2009 | US20090075896 hypotensive polypeptide in dairy product food; milk proteins as inhibitor of angiotensin I-converting enzyme; treating cardiovascular disease |
| 03/19/2009 | US20090075870 Deuterium-enriched caspofungin |
| 03/19/2009 | US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders |
| 03/19/2009 | US20090074864 Novel antimicrobial peptides with heparin binding activity |
| 03/19/2009 | US20090074802 Immunomodulating oligopeptides |
| 03/19/2009 | US20090074779 Neurotrophin-derived peptide sequences |
| 03/19/2009 | US20090074774 Fgfr binding peptides |
| 03/19/2009 | US20090074773 Cancer vaccine |
| 03/19/2009 | US20090074741 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response |
| 03/19/2009 | US20090074663 Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof |
| 03/19/2009 | CA2737126A1 Novel p2x7 epitopes |
| 03/18/2009 | EP2037276A2 Cellular immunity test using peptides fixed to a solid medium |
| 03/18/2009 | EP2036924A2 Gene regulatory peptides |
| 03/18/2009 | EP2036922A1 Novel antihypertensive peptide and use thereof |
| 03/18/2009 | EP2036573A1 HLA binding peptides and their uses |
| 03/18/2009 | EP2036569A2 Method for Treating Secondary Immunodeficiency |
| 03/18/2009 | EP2035443A1 Stabilized vitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 03/18/2009 | EP2035442A1 New supported oxidation reactants, process for their preparation and uses thereof |
| 03/18/2009 | EP1871785A4 Compositions and methods for fusion protein separation |
| 03/18/2009 | EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/18/2009 | EP1386167B1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389642A Cyclic antimicrobial peptides |
| 03/18/2009 | CN101389641A Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 03/18/2009 | CN101386640A Variant cathelicidin-BF15 of cathelicidin-BF and use thereof |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/17/2009 | US7504382 Protease inhibitors for coronaviruses and SARS-CoV and the use thereof |
| 03/17/2009 | US7504381 polymer of positively charged amino acid residues and at least one omega -amino-fatty acid residue; stable, non-toxic and avoiding development of resistance |
| 03/17/2009 | US7504378 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases |
| 03/17/2009 | US7504375 Antimicrobial polypeptides |
| 03/17/2009 | US7504254 Hybridomas; monoclonal antibodies do not cross-react with host tissue polysialic acid and pose minimal risk of autoimmune activity; vaccines; mimetics |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | CA2319094C Antimicrobial peptides |
| 03/17/2009 | CA2191895C Toxin assay |
| 03/12/2009 | WO2009032978A2 Compositions and methods for diagnosing and treating urinary tract infections |